Steatosis and intrahepatic lymphocyte recruitment in hepatitis C virus transgenic mice

Journal of General Virology

Volumn 85, Issue 6, 2004, Pages 1509-1520

  Alonzi, Tonino ^a   Agrati, Chiara ^a   Costabile, Barbara ^b   Cicchini, Carla ^b   Amicone, Laura ^b   Cavallari, Claudio ^a   Della Rocca, Carlo ^b   Folgori, Antonella ^c   Fipaldini, Cristina ^c   Poccia, Fabrizio ^a   La Monica, Nicola ^c   Tripodi, Marco ^a,b  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c IRBM   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; ANTISERUM; CD8 ANTIGEN; CORE PROTEIN; GAMMA INTERFERON; INTERLEUKIN 10; LIVER EXTRACT; MESSENGER RNA; VIRUS PROTEIN; VIRUS RNA; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN RECOGNITION; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; CYTOKINE RELEASE; GENE EXPRESSION; GENE INSERTION; HEPATITIS C VIRUS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; IN SITU HYBRIDIZATION; IN VITRO STUDY; LIVER NECROSIS; LYMPHOCYTE MIGRATION; LYMPHOCYTIC INFILTRATION; MITOGENESIS; NATURAL KILLER CELL; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPLEEN CELL; STEATOSIS; T LYMPHOCYTE; TRANSGENIC MOUSE; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL MOTION; FATTY LIVER; GENETICS; HEPATITIS C; IMMUNOLOGY; LIVER; LYMPHOCYTE; MOUSE; PATHOLOGY; PHYSIOLOGY;

ANIMALIA; HEPATITIS C VIRUS; MUS MUSCULUS;

ALPHA 1-ANTITRYPSIN; ANIMALS; CELL MOVEMENT; CYTOKINES; FATTY LIVER; HEPACIVIRUS; HEPATITIS C; IMMUNOHISTOCHEMISTRY; LIVER; LYMPHOCYTES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC;

EID: 2942689783     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.19724-0     Document Type: Article

References (57)

1. Agrati, C., D'Offizi, G., Narciso, P., Abrignani, S., Ippolito, G., Colizzi, V. & Poccia, F. (2001). Vδ1 T lymphocytes expressing a Th1 phenotype are the major γδT cell subset infiltrating the liver of HCV-infected persons. Mol Med 7, 11-19.
2. Akdis, C. A. & Blaser, K. (2001). Mechanisms of interleukin-10-mediated immune suppression. Immunology 103, 131-136.
3. Amicone, L., Galimi, M. A., Spagnoli, F. M., Tommasini, C., De Luca, V. & Tripodi, M. (1995). Temporal and tissue-specific expression of the MET ORF driven by the complete transcriptional unit of human A1AT gene in transgenic mice. Gene 162, 323-328.
4. Amicone, L., Spagnoli, F. M., Spath, G. & 8 other authors (1997). Transgenic expression in the liver of truncated Met blocks apoptosis and permits immortalization of hepatocytes. EMBO J 16, 495-503.
5. Armstrong, G. L., Alter, M. J., McQuillan, G. M. & Margolis, H. S. (2000). The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States. Hepatology 31, 777-782.
6. Bach, N., Thung, S. N. & Schaffner, F. (1992). The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis. Hepatology 15, 572-577.
7. Bertoletti, A. & Maini, M. K. (2000). Protection or damage: a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection? Curr Opin Microbiol 3, 387-392.
8. Bianchi, L., Desmet, V. J., Popper, H., Scheuer, P. J., Aledort, L. M. & Berk, P. D. (1987). Histologic patterns of liver disease in hemophiliacs, with special reference to morphologic characteristics of non-A, non-B hepatitis. Semin Liver Dis 7, 203-209.
9. Blindenbacher, A., Duong, F. H., Hunziker, L. & 9 other authors (2003). Expression of hepatitis C virus proteins inhibits interferon α signalling in the liver of transgenic mice. Gastroenterology 124, 1465-1475.
10. Bloch, B. (1993). Biotinylated probes for in situ hybridization histochemistry: use for mRNA detection. J Histochem Cytochem 41, 1751-1754.
11. Cerny, A. & Chisari, F. V. (1999). Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence. Hepatology 30, 595-601.
12. Choo, Q. L., Kuo, G., Weiner, A. J., Overby, L. R., Bradley, D. W. & Houghton, M. (1989). Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244, 359-362.
13. Choo, Q. L., Richman, K. H. Han, J. H. & 11 other authors (1991). Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci U S A 8, 2451-2455.
14. Clarke, B. (1997). Molecular virology of hepatitis C virus. J Gen Virol 78, 2397-2410.
15. Duong, F. H., Filipowicz, M., Tripodi, M., La Monica, N. & Heim, M. H. (2004). Hepatitis C virus inhibits interferon signaling through upregulation of protein phosphatase 2A. Gastroenterology 126, 263-277.
16. Eckart, M. R., Selby, M., Masiarz, F. & 7 other authors (1993). The hepatitis C virus encodes a serine protease involved in processing of the putative nonstructural proteins from the viral polyprotein precursor. Biochem Biophys Res Commun 192, 399-406.
17. Esposito, G., Scarselli, E., Cerino, A., Mondelli, M. U., La Monica, N. & Traboni, C. (1995). A human antibody specific for hepatitis C virus core protein: synthesis in a bacterial system and characterization. Gene 164, 203-209.
18. Fimia, G. M., Tripodi, M. & Alonzi, T. (2003). Transgenic models for hepatitis C virus pathogenesis. Cell Death Differ 10, S16-18.
19. + T-cell response in acute hepatitis C. Gastroenterology 117, 933-941.
20. Ghosh, A. K., Steele, R., Meyer, K., Ray, R. & Ray, R. B. (1999). Hepatitis C virus NS5A protein modulates cell cycle regulatory genes and promotes cell growth. J Gen Virol 80, 1179-1183.
21. Gonzales-Peralta, R. P., Davis, G. L. & Lau, J. Y. (1994). Pathogenic mechanism of hepatocellular damage in chronic hepatitis C. J Hepatol 21, 255-259.
22. Grakoui, A., Wychowski, C., Lin, C., Feinstone, S. M. & Rice, C. M. (1993). Expression and identification of hepatitis C virus polyprotein cleavage products. J Virol 67, 1385-1395.
23. Griffin, S. D. C., Harvey, R., Clarke, D. S., Barclay, W. S., Harris, M. & Rowlands, D. J. (2004). A conserved basic loop in hepatitis C virus p7 protein is required for amantadine-sensitive ion-channel activity in mammalian cells but is dispensable for localization to mitochondria. J Gen Virol 85, 451-461.
24. Gruner, N. H., Gerlach, T. J., Jung, M. C. & 9 other authors (2000). Association of hepatitis C virus-specific CD8 + T cells with viral clearance in acute hepatitis C. J Infect Dis 181, 1528-1536.
25. Hijikata, M., Mizushima, H., Akagi, T., Mori, S., Kakiuchi, N., Kato, N., Tanaka, T., Kimura, K. & Shimotohno, K. (1993a). Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus. J Virol 67, 4665-4675.
26. Hijikata, M., Mizushima, H., Tanji, Y., Komoda, Y., Hirowatari, Y., Akagi, T., Kato, N., Kimura, K. & Shimotohno, K. (1993b). Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virus. Proc Natl Acad Sci U S A 90, 10773-10777.
27. Hogan, B., Costantini, F. & Lacey, E. (1996). Manipulating the Mouse Embryo. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
28. Houghton, M., Weiner, A., Han, J., Kuo, G. & Choo, Q. L. (1991). Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology 14, 381-388.
29. Kato, N., Hijikata, M., Ootsuyama, Y., Nakagawa, M., Ohkoshi, S., Sugimura, T. & Shimotohno, K. (1990). Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci U S A 87, 9524-9528.
30. Koike, K. (1999). Transgenic mouse models of viral hepatitis: insight into viral hepatocarcinogenesis. Viral Hepatol 5, 177-203.
31. Kuo, G., Choo, Q. L., Alter, H. J. & 17 other authors (1989). An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244, 362-364.
32. Lauer, G. M. & Walker, B. D. (2001). Hepatitis C virus infection. N Engl J Med 345, 41-52.
33. Lerat, H., Honda, M., Beard, M. R. & 7 other authors (2002). Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus. Gastroenterology 122, 352-365.
34. Lin, C., Pragai, B. M., Grakoui, A., Xu, J. & Rice, C. M. (1994). Hepatitis C virus NS3 serine proteinase: trans-cleavage requirements and processing kinetics. J Virol 68, 8147-8157.
35. Marusawa, H., Hijikata, M., Chiba, T. & Shimotohno, K. (1999). Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-κB activation. J Virol 73, 4713-4720.
36. Mizushima, H., Hijikata, M., Asabe, S., Hirota, M., Kimura, K. & Shimotohno, K. (1994). Two hepatitis C virus glycoprotein E2 products with different C termini. J Virol 68, 6215-6222.
37. Moore, K. W., de Waal Malefyt, R., Coffman, R. L. & O'Garra, A. (2001). Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19, 683-765.
38. Moriya, K., Yotsuyanagi, H., Shintani, Y., Fujie, H., Ishibashi, K., Matsuura, Y., Miyamura, T. & Koike, K. (1997). Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. J Gen Virol 78, 1527-1531.
39. Moriya, K., Nakagawa, K., Santa, T. & 11 other authors (2001). Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res 61, 4365-4370.
40. Napoli, J., Bishop, G. A., McGuinness, P. H., Painter, D. M. & McCaughan, G. W. (1996). Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology 24, 759-765.
41. Nelson, D. R., Tu, Z., Soldevila-Pico, C., Abdelmalek, M., Zhu, H., Xu, Y. L., Cabrera, R., Liu, C. & Davis, G. L. (2003). Long-term interleukin 10 therapy in chronic hepatitis C patients has a proviral and anti-inflammatory effect. Hepatology 38, 859-868.
42. Nuti, S., Rosa, D., Valiante, N. M., Saletti, G., Caratozzolo, M., Dellabona, P., Barnaba, V. & Abrignani, S. (1998). Dynamics of intra-hepatic lymphocytes in chronic hepatitis C: enrichment for Vα24+ T cells and rapid elimination of effector cells by apoptosis. Eur J Immunol 28, 3448-3455.
43. Okuda, M., Li, K., Beard, M. R., Showalter, L. A., Scholle, F., Lemon, S. M. & Weinman, S. A. (2002). Mitochondrial injury, oxidative stress and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 122, 366-375.
44. Park, J. S., Yang, J. M. & Min, M. K. (2000). Hepatitis C virus nonstructural protein NS4B transforms NIH3T3 cells in cooperation with the Ha-ras oncogene. Biochem Biophys Res Comm 267, 581-589.
45. Ray, R. B., Lagging, L. M., Meyer, K. & Ray, R. (1996). Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. J Virol 70, 4438-4443.
46. Ruggieri, A., Harada, T., Matsuura, Y. & Miyamura, T. (1997). Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein. Virology 229, 68-76.
47. Ruther, U., Tripodi, M., Cortese, R. & Wagner, E. F. (1987). The human alpha-1-antitrypsin gene is efficiently expressed from two tissue-specific promoters in transgenic mice. Nucleic Acids Res 15, 7519-7529.
48. Sakamuro, D., Furukawa, T. & Takegami, T. (1995). Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells. J Virol 69, 3893-3896.
49. Santolini, E., Migliaccio, G. & La Monica, N. (1994). Biosynthesis and biochemical properties of the hepatitis C virus core protein. J Virol 68, 3631-3641.
50. Takamizawa, A., Mori, C., Fuke, I. & 7 other authors (1991). Structure and organization of the hepatitis C virus genome isolated from human carriers. J Virol 65, 1105-1113.
51. Tan, S. L., Nakao, H., He, Y., Vijaysri, S., Neddermann, P., Jacobs, B. L., Mayer, B. J. & Katze, M. G. (1999). NS5A, a nonstructural protein of hepatitis C virus, binds growth factor receptor-bound protein 2 adaptor protein in a Src homology 3 domain/ligand-dependent manner and perturbs mitogenic signaling. Proc Natl Acad Sci U S A 96, 5533-5538.
52. Tanaka, S., Takenaka, K., Matsumata, T., Mori, R. & Sugimachi, K. (1996). Hepatitis C virus replication is associated with expression of transforming growth factor-alpha and insulin-like growth factor-II in cirrhotic livers. Dig Dis Sci 41, 208-215.
53. Tomei, L., Failla, C., Santolini, E., De Francesco, R. & La Monica, N. (1993). NS3 is a serine protease required for processing of hepatitis C virus polyprotein. J Virol 67, 4017-4026.
54. Tripodi, M., Perfumo, S., Ali, R., Amicone, L., Abbott, C. & Cortese, R. (1990). Generation of small mutation in large genomic fragments by homologous recombination: description of the technique and examples of its use. Nucleic Acids Res 18, 6247-6251.
55. Tsai, S. L., Liaw, Y. F., Chen, M. H., Huang, C. Y. & Kuo, G. C. (1997). Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity. Hepatology 25, 449-458.
56. Woitas, R. P., Lechmann, M., Jung, G., Kaiser, R., Sauerbruch, T. & Spengler, U. (1997). CD30 induction and cytokine profiles in hepatitis C virus core-specific peripheral blood T lymphocytes. J Immunol 159, 1012-1018.
57. Zucchelli, S., Capone, S., Fattori, E. & 8 other authors (2000). Enhancing B- and T-cell immune response to a hepatitis C virus E2 DNA vaccine by intramuscular electrical gene transfer. J Virol 74, 11598-11607.